Palbociclib Plus Letrozole For Postmenopausal Women With HR(+) HER2(-) Advanced Breast Cancer For Whom Letrozole Is Deemed Appropriate

NCT02600923 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

131

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Breast Cancer Female

Interventions

DRUG: Palbociclib
DRUG: Letrozole

Sponsor

Pfizer